Tacrolimus

BH3 interacting domain death agonist ; Homo sapiens







22 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32247597 Conversion From a Twice-Daily to a Once-Daily Tacrolimus Formulation in Kidney Transplant Recipients. 2020 Oct 2
2 30318624 Once-daily vs twice-daily tacrolimus for de novo living kidney transplantation patients including ABO/HLA compatible and incompatible: A randomized trial. 2018 Dec 1
3 26373896 Advagraf(®) , a once-daily prolonged release tacrolimus formulation, in kidney transplantation: literature review and guidelines from a panel of experts. 2016 Aug 1
4 26953629 LCPT once-daily extended-release tacrolimus tablets versus twice-daily capsules: a pooled analysis of two phase 3 trials in important de novo and stable kidney transplant recipient subgroups. 2016 May 1
5 27011912 Overview of extended release tacrolimus in solid organ transplantation. 2016 Mar 24 6
6 24680768 Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. 2014 May 1
7 24981811 Case report: boldo (Peumus boldus) and tacrolimus interaction in a renal transplant patient. 2014 Sep 2
8 23483701 Conversion from twice daily tacrolimus to once daily tacrolimus in long-term stable liver transplant recipients: a single-center experience with 394 patients. 2013 May 1
9 23622676 Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. 2013 Apr 2
10 21992068 Renal function and safety in stable kidney transplant recipients converted from immediate-release to prolonged-release tacrolimus. 2012 Jan 1
11 22239105 Renal function, efficacy and safety postconversion from twice- to once-daily tacrolimus in stable liver recipients: an open-label multicenter study. 2012 Mar 2
12 22249344 Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. 2012 Feb 1
13 22310593 Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients. 2012 Jan 5
14 22406656 Tacrolimus pharmacokinetics of once- versus twice-daily formulations in de novo kidney transplantation: a substudy of a randomized phase III trial. 2012 Apr 8
15 23082898 One-year follow-up of treatment with once-daily tacrolimus in de novo renal transplant. 2012 Dec 2
16 21099736 Cervical multilevel intraspinal stem cell therapy: assessment of surgical risks in Gottingen minipigs. 2011 Feb 1 1
17 21280190 Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: a randomized, open-label trial. 2011 Feb 4
18 21493098 Pharmacokinetics in stable heart transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. 2011 Sep 2
19 20840480 Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study. 2010 Dec 2
20 20840481 Once-daily prolonged-release tacrolimus (ADVAGRAF) versus twice-daily tacrolimus (PROGRAF) in liver transplantation. 2010 Oct 2
21 19681813 Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial. 2009 Nov 5
22 12884468 Annular erythema responding to tacrolimus ointment. 2003 Aug 1